These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33622990)

  • 1. Prevalence of UGT1A1 (TA)n promoter polymorphism in Panamanians neonates with G6PD deficiency.
    Chávez-Peña T; Martínez-Camberos A; Cossio-Gurrola G; Arámbula-Meraz E; Herrera-Rodríguez I; Romo-Martínez E; García-Magallanes N
    J Genet; 2020; 99():. PubMed ID: 33622990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia.
    Huang CS; Chang PF; Huang MJ; Chen ES; Chen WC
    Gastroenterology; 2002 Jul; 123(1):127-33. PubMed ID: 12105841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UDP-glucuronosyltransferase promoter polymorphism in Iranian neonates with idiopathic hyperbilirubinemia.
    Kaveh M; Esmailnia T; Nayeri F; Nili F; Davari Tanha F; Ghajarzdeh M
    Acta Med Iran; 2013; 51(11):789-92. PubMed ID: 24390949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes.
    Henriksen JN; Bøttger P; Hermansen CK; Ladefoged SA; Nissen PH; Hamilton-Dutoit S; Fink TL; Donskov F
    Clin Genitourin Cancer; 2020 Feb; 18(1):62-68.e2. PubMed ID: 31640912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of UGT1A1 promoter polymorphism and exon-1 mutations in neonatal jaundice.
    Halis H; Ergin H; Köseler A; Atalay EÖ
    J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2658-2664. PubMed ID: 27842454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism.
    Mobaraki S; Nissen PH; Donskov F; Wozniak A; Van Herck Y; Coosemans L; van Nieuwenhuyse T; Lambrechts D; Bechter O; Baldewijns M; Roussel E; Laenen A; Beuselinck B
    Clin Genitourin Cancer; 2024 Oct; 22(5):102180. PubMed ID: 39155162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia.
    Agrawal SK; Kumar P; Rathi R; Sharma N; DAS R; Prasad R; Narang A
    Pediatr Res; 2009 Jun; 65(6):675-80. PubMed ID: 19430380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of glucose-6-phosphate dehydrogenase and UDP-glucuronosyltransferase 1A1 in the development of neonatal unconjugated hyperbilirubinemia.
    Hung YL; Chang PF; Huang CS
    Pediatr Neonatol; 2024 Sep; 65(5):419-426. PubMed ID: 38480019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates.
    Kaplan M; Slusher T; Renbaum P; Essiet DF; Pam S; Levy-Lahad E; Hammerman C
    Pediatr Res; 2008 Jan; 63(1):109-11. PubMed ID: 18043502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
    Hamad Z; Aljedai A; Halwani R; AlSultan A
    Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme oxygenase-1 promoter polymorphisms and neonatal jaundice.
    Kaplan M; Renbaum P; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Neonatology; 2014; 106(4):323-9. PubMed ID: 25277974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-inheritance of G6PD deficiency and 211 G to a variation of UGT1A1 in neonates with hyperbilirubinemia in eastern Guangdong.
    Xu JX; Lin F; Chen ZK; Luo ZY; Zhan XF; Wu JR; Ma YB; Li JD; Yang LY
    BMC Pediatr; 2021 Dec; 21(1):564. PubMed ID: 34895177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.
    Toffoli G; Cecchin E; Corona G; Russo A; Buonadonna A; D'Andrea M; Pasetto LM; Pessa S; Errante D; De Pangher V; Giusto M; Medici M; Gaion F; Sandri P; Galligioni E; Bonura S; Boccalon M; Biason P; Frustaci S
    J Clin Oncol; 2006 Jul; 24(19):3061-8. PubMed ID: 16809730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UGT1A1*28 gene polymorphism was not associated with the risk of neonatal hyperbilirubinemia: a meta-analysis.
    Li H; Zhang P
    J Matern Fetal Neonatal Med; 2021 Dec; 34(24):4064-4071. PubMed ID: 31818155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase (G6PD) mutations and UDP-glucuronosyltransferase promoter polymorphism among G6PD deficient Kuwaitis.
    Samilchuk E; Al-Suliman I; Usanga E; Al Awadi S
    Blood Cells Mol Dis; 2003; 31(2):201-5. PubMed ID: 12972027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.
    Kringen MK; Piehler AP; Grimholt RM; Opdal MS; Haug KB; Urdal P
    PLoS One; 2014; 9(2):e90248. PubMed ID: 24587300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.
    Liu CY; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
    Cancer; 2008 May; 112(9):1932-40. PubMed ID: 18300238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.
    Yang H; Wang Q; Zheng L; Zheng XB; Lin M; Zhan XF; Yang LY
    Pediatr Neonatol; 2016 Aug; 57(4):310-7. PubMed ID: 26727668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates.
    Kaplan M; Renbaum P; Vreman HJ; Wong RJ; Levy-Lahad E; Hammerman C; Stevenson DK
    Pediatr Res; 2007 Jun; 61(6):727-31. PubMed ID: 17426648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.